Healthcare / Medical Care FacilitiesHKSE
$22.28
+0.62 (+2.86%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 23%
FCF escenarios
weak_data · normalized FCF $111.9M · quality 51.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
46/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.4B
P/E
8.9x
↓EV/EBITDA
5.0x
↓ROE
-8.3%
↓Gross Margin
25.1%
↓Debt/Equity
-0.18
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+31.0%
FCF CAGR
—
FCF margin
13.7%
FCF / Net income
1.08x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.06B · net income $135.1M · FCF $145.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.06B | $1.06B | $958.6M | $690.4M | $473.2M |
| Net Income | $135.1M | $135.1M | $83.8M | $-350.7M | $-215.5M |
| EBITDA | $281.4M | $281.4M | $232.2M | $-219.1M | $-112.7M |
| EPS | — | — | 1.30 | -5.45 | -3.35 |
| Gross Margin | 25.1% | 25.1% | 23.6% | 19.3% | 9.3% |
| Operating Margin | 2.9% | 2.9% | -5.5% | -8.0% | -31.9% |
| Net Margin | 12.7% | 12.7% | 8.7% | -50.8% | -45.5% |
| Balance Sheet | |||||
| Debt/Equity | -0.18 | -0.18 | -0.19 | -0.18 | -0.22 |
| Current Ratio | 0.25 | 0.25 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $145.8M | $145.8M | $111.9M | $55.7M | $-83.4M |
| Returns | |||||
| ROE | -8.3% | -8.3% | -4.7% | 19.9% | 15.3% |
| Valuation | |||||
| P/E | 8.95 | 8.95 | — | — | — |
| EV/EBITDA | 4.97 | 4.97 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 11.1% | 11.1% | 38.8% | 45.9% | — |
| EPS Growth | — | — | 123.9% | -62.7% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-67.2%
Start / end P/E
n/dx → n/dx
EPS bridge
1.30 → n/d
Residual
-67.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.